Clonality of HTLV-2 in Natural Infection

English version České info

The two human retroviruses HTLV-1 and HTLV-2 are similar in their structure, replication cycle and the manner through which they spread between and within individuals. They differ in their preferred host T-cell type and in their possible clinical outcomes. HTLV-2 has not been linked with a specific disease, whereas HTLV-1 infection can cause leukemia and profound neuropathology. It is well established that HTLV-1-infected cells undergo clonal expansion in infected individuals, but little is known about clonality in HTLV-2 infection. In this work, we demonstrate that the extent of HTLV-2-infected cell expansion significantly exceeds that of HTLV-1-infected cells in healthy carriers, approximating instead to that observed in patients with HTLV-1-associated leukemia. Furthermore, we show that HTLV-2 characteristically resides in a small number of expanded clones that persist over time, and that the degree of oligoclonality significantly correlates with viral burden in HTLV-2-infected individuals. These results highlight the distinction between in vivo clonal proliferation and malignant transformation, and suggest that the infected cell type may be a more important determinant of clinical outcome in retroviral infections.

Vyšlo v časopise: Clonality of HTLV-2 in Natural Infection. PLoS Pathog 10(3): e32767. doi:10.1371/journal.ppat.1004006
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004006

Souhrn

Zdroje

1. SalemiM, DesmyterJ, VandammeAM (2000) Tempo and mode of human and simian T-lymphotropic virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences. Mol Biol Evol 17 : 374–386.

2. AkagiT, ShimotohnoK (1993) Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J Virol 67 : 1211–1217.

3. RossTM, PettifordSM, GreenPL (1996) The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol 70 : 5194–5202.

4. RoucouxDF, MurphyEL (2004) The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 6 : 144–154.

5. GessainA, CassarO (2012) Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol 3 : 388.

6. OrlandJR, EngstromJ, FrideyJ, SacherRA, SmithJW, et al. (2003) Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61 : 1588–1594.

7. BiswasHH, EngstromJW, KaidarovaZ, GarrattyG, GibbleJW, et al. (2009) Neurologic abnormalities in HTLV-I -⁠ and HTLV-II-infected individuals without overt myelopathy. Neurology 73 : 781–789.

8. AraujoA, HallWW (2004) Human T-lymphotropic virus type II and neurological disease. Ann Neurol 56 : 10–19.

9. BiswasHH, KaidarovaZ, GarrattyG, GibbleJW, NewmanBH, et al. (2010) Increased all-cause and cancer mortality in HTLV-II infection. J Acquir Immune Defic Syndr 54 : 290–296.

10. BartmanMT, KaidarovaZ, HirschkornD, SacherRA, FrideyJ, et al. (2008) Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood 112 : 3995–4002.

11. ManelN, KimFJ, KinetS, TaylorN, SitbonM, et al. (2003) The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115 : 449–459.

12. IjichiS, RamundoMB, TakahashiH, HallWW (1992) In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J Exp Med 176 : 293–296.

13. LalRB, OwenSM, RudolphDL, DawsonC, PrinceH (1995) In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells. Virology 210 : 441–447.

14. JonesKS, FugoK, Petrow-SadowskiC, HuangY, BertoletteDC, et al. (2006) Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol 80 : 8291–8302.

15. KannianP, YinH, DoueiriR, LairmoreMD, FernandezS, et al. (2012) Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol 86 : 3757–3766.

16. ChenIS, QuanSG, GoldeDW (1983) Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci U S A 80 : 7006–7009.

17. TarsisSL, YuMT, ParksES, PersaudD, MunozJL, et al. (1998) Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2. J Virol 72 : 841–846.

18. FurukawaY, FujisawaJ, OsameM, ToitaM, SonodaS, et al. (1992) Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood 80 : 1012–1016.

19. WattelE, VartanianJP, PannetierC, Wain-HobsonS (1995) Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 69 : 2863–2868.

20. CimarelliA, DuclosCA, GessainA, CasoliC, BertazzoniU (1996) Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load. Virology 223 : 362–364.

21. GabetAS, MoulesV, SibonD, NassCC, MortreuxF, et al. (2006) Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology 345 : 13–21.

22. MatsuokaM, JeangKT (2011) Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30 : 1379–1389.

23. GilletNA, MalaniN, MelamedA, GormleyN, CarterR, et al. (2011) The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117 : 3113–3122.

24. MelamedA, LaydonDJ, GilletNA, TanakaY, TaylorGP, et al. (2013) Genome-wide Determinants of Proviral Targeting, Clonal Abundance and Expression in Natural HTLV-1 Infection. PLoS Pathog 9: e1003271.

25. WattelE, CavroisM, GessainA, Wain-HobsonS (1996) Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol 13 Suppl 1: S92–99.

26. HiguchiM, FujiiM (2009) Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. Retrovirology 6 : 117.

27. GilletNA, GutierrezG, RodriguezSM, de BrogniezA, RenotteN, et al. (2013) Massive Depletion of Bovine Leukemia Virus Proviral Clones Located in Genomic Transcriptionally Active Sites during Primary Infection. PLoS Pathog 9: e1003687.

28. GilletNA, CookL, LaydonDJ, HlelaC, VerdonckK, et al. (2013) Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo. PLoS Pathog 9: e1003263.

29. CookLB, ElemansM, RowanAG, AsquithB (2013) HTLV-1: persistence and pathogenesis. Virology 435 : 131–140.

30. Gini C (1912) Variabilità e Mutuabilità. Contributo allo Studio delle Distribuzioni e delle Relazioni Statistiche. C. Cuppini, Bologna.

31. MeekingsKN, LeipzigJ, BushmanFD, TaylorGP, BanghamCR (2008) HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog 4: e1000027.

32. SieburgM, TrippA, MaJW, FeuerG (2004) Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis. J Virol 78 : 10399–10409.

33. RobekMD, RatnerL (1999) Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73 : 4856–4865.

34. AsquithB, ZhangY, MosleyAJ, de LaraCM, WallaceDL, et al. (2007) In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A 104 : 8035–8040.

35. MurphyEL, HanchardB, FigueroaJP, GibbsWN, LoftersWS, et al. (1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 43 : 250–253.

36. YamaguchiK, WatanabeT (2002) Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 76 Suppl 2 : 240–245.

37. TsubataC, HiguchiM, TakahashiM, OieM, TanakaY, et al. (2005) PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line. Retrovirology 2 : 46.

38. RenT, DongW, TakahashiY, XiangD, YuanY, et al. (2012) HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy. J Biol Chem 287 : 34683–34693.

39. ImaiM, HiguchiM, KawamuraH, YoshitaM, TakahashiM, et al. (2013) Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells. Virus Genes 46 : 39–46.

40. BanghamCR (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39 : 1700–1712.

41. BanghamCR, MeekingsK, ToulzaF, NejmeddineM, MajorovitsE, et al. (2009) The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci 14 : 2889–2903.

42. KannagiM, HaradaS, MaruyamaI, InokoH, IgarashiH, et al. (1991) Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 3 : 761–767.

43. GoonPK, BiancardiA, FastN, IgakuraT, HanonE, et al. (2004) Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis 189 : 2294–2298.

44. OliveiraAL, HayakawaH, SchorD, LeiteAC, EspindolaOM, et al. (2009) High frequencies of functionally competent circulating Tax-specific CD8+ T cells in human T lymphotropic virus type 2 infection. J Immunol 183 : 2957–2965.

45. WangTG, YeJ, LairmoreMD, GreenPL (2000) In vitro cellular tropism of human T cell leukemia virus type 2. AIDS Res Hum Retroviruses 16 : 1661–1668.

46. CasoliC, CimarelliA, BertazzoniU (1995) Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocytes in patients with high proviral load. Virology 206 : 1126–1128.

47. RenT, ChengH (2013) Differential transforming activity of the retroviral Tax oncoproteins in human T lymphocytes. Front Microbiol 4 : 287.

48. BarbeauB, PeloponeseJM, MesnardJM (2013) Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front Microbiol 4 : 226.

49. MurphyEL, WatanabeK, NassCC, OwnbyH, WilliamsA, et al. (1999) Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J Infect Dis 180 : 1777–1783.

50. KattanT, MacNamaraA, RowanAG, NoseH, MosleyAJ, et al. (2009) The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol 182 : 5723–5729.

51. LeeTH, ChafetsDM, BuschMP, MurphyEL (2004) Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol 31 : 275–282.

52. KwaanN, LeeTH, ChafetsDM, NassC, NewmanB, et al. (2006) Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 194 : 1557–1564.

53. BlankenbergD, Von KusterG, CoraorN, AnandaG, LazarusR, et al. (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol Chapter 19 Unit 19 10 11–21.

54. GoecksJ, NekrutenkoA, TaylorJ, GalaxyT (2010) Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 11: R86.

55. CookLB, RowanAG, MelamedA, TaylorGP, BanghamCR (2012) HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 120 : 3488–3490.

56. Handcock MS, Morris M (1999) Relative distribution methods in the social sciences. New York: Springer. xiii, 265 p.